Since cellular immunity is not routinely determined, these results could help to understand the correlation between humoral and cellular immune responses and could contribute to better management of these immunocompromised patients on anti-TNFα inhibitors in the COVID-19 setting. This evidence concerns the gene TNF and COVID-19.